Active Ingredient: SUMATRIPTAN SUCCINATE
Proprietary Name: SUMATRIPTAN SUCCINATE
Dosage Form; Route of Administration: INJECTABLE; SUBCUTANEOUS
Strength: EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A200183
Product Number: 001
Approval Date: Sep 16, 2013
Applicant Holder Full Name: HIKMA FARMACEUTICA PORTUGAL SA
Marketing Status:
Prescription
Patent and Exclusivity Information
